$3,000,000.00                                                       May   , 2006


                           BUSINESS PROMISSORY NOTE
                           ------------------------

     FOR VALUE RECEIVED,  Synovics  Pharmaceuticals,  Inc., a Nevada corporation
("Borrower"),  promises to pay to the order of John S. Copanos ("LENDER"), Three
Million Dollars ($3,000,000.00),with interest, as provided herein.

     1.   PRINCIPAL PAYMENTS.  The principal amount of this Note shall be due in
a lump sum three (3) years from the date hereof (the "Maturity Date").

     2.   PREPAYMENTS.  Principal  amounts  outstanding  under  this Note may be
prepaid  at any time at the  option of  Borrower,  in whole or in part,  without
premium or penalty.

     3.   INTEREST  PAYMENTS.  This  Note  shall  bear  interest  on the  unpaid
principal balance from the date hereof at the rate of seven and one half percent
(7 1/2%) per annum,  payable on the date twelve (12) months from the date hereof
and each twelve (12) months thereafter until the Maturity Date.

     4.   METHOD OF PAYMENT.  All  payments of principal  and interest  shall be
made by the transfer of  immediately  available  funds to such account as Lender
shall designate from time to time. If any payment date shall fall on a day other
than a business  day,  the payment due on such date shall be payable on the next
succeeding business day.

     5.   DEFAULT.  A default  shall  exist upon the  failure by Borrower to pay
when due the interest on the unpaid  principal  evidenced  by this Note,  upon a
failure to comply with any of the other terms, provisions and conditions of this
Note,  or upon a  failure  to pay the  principal  when  due,  and  such  default
continues for a period of sixty (60) days following  written notice from Lender.
If at any time Lender incurs costs in respect of the collection of  indebtedness
hereunder,  including attorneys' fees and expenses,  Lender shall be entitled to
immediate reimbursement from the Borrower for all such costs incurred (or at his
option elect to add such amounts to the principal balance of the indebtedness).

     6.   GOVERNING  LAW.  This  Note  shall be  governed  by and  construed  in
accordance  with the laws of the State of  Florida  excluding  the  conflict  or
choice of law principles  thereof,  and any suit brought in connection  with the
enforcement or  interpretation  of this Note may be brought in the courts of the
State of Florida or the federal courts in Florida.  Borrower hereby  irrevocably
submits to the non-exclusive jurisdiction of such courts.

     7.   MISCELLANEOUS.  Presentment,  notices of dishonor and demand,  protest
and diligence in collection and bringing suit are hereby severally waived by the
Borrower.  No waiver of any default or failure or delay to exercise any right or
remedy by the holders of

<PAGE>


this Note shall  operate as a waiver of any right or remedy with  respect to the
same or any other occurrences.  This written Note represents the final agreement
between  the  parties  and  my  not  be   contradicted  by  evidence  of  prior,
contemporaneous,  or subsequent,  oral  agreements of the parties.  There are no
unwritten oral agreements between the parties.

     8.   WAIVER OF JURY TRIAL.  IN ANY COURT ACTION RELATING TO THIS NOTE, EACH
OF BORROWER AND LENDER WAIVES ANY RIGHT TO TRIAL BY JURY.

     IN WITNESS  WHEREOF,  Borrower  has caused  this Note to be executed by its
duly authorized officers.

                                            SYNOVICS PHARMACEUTICALS, INC.

Attest:

                                            By: /s/ Ronald Howard Lane
                                                --------------------------------
                                                     Ronald Howard Lane, PhD
                                                     Chairman, CEO and President

[illegible]
-----------
Secretary


                                     NOTICE

THIS NOTE HAS NOT BEEN  REGISTERED  PURSUANT TO THE  SECURITIES  ACT OF 1933, AS
AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE MAY NOT BE OFFERED
OR SOLD UNLESS IT IS REGISTERED  UNDER THE APPLICABLE  SECURITIES LAWS OR UNLESS
AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.